Verastem, Inc. (VSTM)
6.38
+0.23
(+3.74%)
USD |
NASDAQ |
Mar 06, 16:00
6.30
-0.08
(-1.25%)
After-Hours: 20:00
Verastem SG&A Expense (TTM) : 56.70M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Altimmune, Inc. | 28.10M |
| ADMA Biologics, Inc. | 96.42M |
| Ocugen, Inc. | 21.45M |
| Zevra Therapeutics, Inc. | 73.39M |
| Immuneering Corp. | 12.81M |